Michael Leonidas Chikindas

Dr. Michael Leonidas Chikindas

School of Environmental and Biological Sciences, The State University of New Jersey, 65 Dudley Road, New Brunswick, NJ 08901-8520, USA
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Current Opinion in Biotechnology
Verified
Journal Article
Closed access
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas
RWRichard Weeks
Richard Weeks
DDDjamel Drider
Djamel Drider
VCVladimir Anatolievich Chistyakov
Vladimir Anatolievich Chistyakov
LDLeon Mt Dicks
Leon Mt Dicks

1 February 2017 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
PDF file
AAAmmar R. Algburi
Ammar R. Algburi
NCNicole Comito
Nicole Comito
DKDimitri Kashtanov
Dimitri Kashtanov
LDLeon M. T. Dicks
Leon M. T. Dicks
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas
Biofilm-associated bacteria are less sensitive to antibiotics than free-living (planktonic) cells. Furthermore, with variations in the concentration of antibiotics throughout a biofilm, microbial cells are often exposed to levels below inhibitory concentrations and may develop resistance. This, as well as the irresponsible use of antibiotics, leads to the selection of pathogens that are difficult to eradicate. The Centers for Disease Control and Prevention use the terms “antibiotic” and “antimicrobial agent” interchangeably. However, a clear distinction between these two terms is required for the purpose of this assessment. Therefore, we define “antibiotics” as pharmaceutically formulated and medically administered substances and “antimicrobials” as a broad category of substances which are not regulated as drugs. This comprehensive minireview evaluates the effect of natural antimicrobials on pathogens in biofilms when used instead of, or in combination with, commonly prescribed antibiotics.

1 June 1998 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
VRvan Reenen
van Reenen
LDLeon Dicks
Leon Dicks
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas
Lactobacillus plantarum 423, isolated from sorghum beer, produces a bacteriocin (plantaricin 423) which is inhibitory to several food spoilage bacteria and food-borne pathogens, including Bacillus c...

18 February 2011 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
YTY. Turovskiy
Y. Turovskiy
KNK. Sutyak Noll
K. Sutyak Noll
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas
Bacterial vaginosis (BV) is the most common vaginal infection among women of childbearing age. This condition is notorious for causing severe complications related to the reproductive health of women. Five decades of intense research established many risk factors for acquisition of BV; however, because of the complexity of BV and lack of a reliable animal model for this condition, its exact aetiology remains elusive. In this manuscript, we use a historical perspective to critically review the development of major theories on the aetiology of BV, ultimately implicating BV‐related pathogens, healthy vaginal microbiota, bacteriophages and the immune response of the host. None of these theories on their own can reliably explain the epidemiological data. Instead, BV is caused by a complex interaction of multiple factors, which include the numerous components of the vaginal microbial ecosystem and their human host. Many of these factors are yet to be characterized because a clear understanding of their relative contribution to the aetiology of BV is pivotal to the formulation of an effective treatment for and prophylaxis of this condition.

27 November 2007 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
KSK.E. Sutyak
K.E. Sutyak
RWR.E. Wirawan
R.E. Wirawan
AAA.A. Aroutcheva
A.A. Aroutcheva
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas
Aims: To purify and characterize an antimicrobial protein (bacteriocin) isolated from the dairy product-derived Bacillus amyloliquefaciens. Methods and Results: An unknown bacterial species cultured from the Yogu Farm™ probiotic dairy beverage was identified through 16S ribosomal RNA analysis as B. amyloliquefaciens, a phylogenetically close relative of Bacillus subtilis. The cell-free supernatant (CFS) of overnight cultures was active against Listeria monocytogenes and also against clinical isolates of Gardnerella vaginalis and Streptococcus agalactiae. At the same time, several isolates of vaginal probiotic Lactobacilli were resistant to the CFS. The nature of the compound causing inhibitory activity was confirmed as proteinaceous by enzymatic digestion. The protein was isolated using ammonium sulfate precipitation, and further purified via column chromatography. PCR analysis was conducted to determine relatedness to other bacteriocins produced by Bacillus spp. Conclusion: The antimicrobial protein isolated from B. amyloliquefaciens was shown to be subtilosin, a bacteriocin previously reported as produced only by B. subtilis. Significance and Impact of the Study: This is the first report of intra-species horizontal gene transfer for subtilosin and the first fully characterized bacteriocin isolated from B. amyloliquefaciens. Finally, this is the first report on subtilosin’s activity against bacterial vaginosis-associated pathogens.

1 November 2015 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
VCVeronica L. Cavera
Veronica L. Cavera
TATimothy D. Arthur
Timothy D. Arthur
DKDimitri Kashtanov
Dimitri Kashtanov
Michael Leonidas ChikindasMichael Leonidas Chikindas
Michael Leonidas Chikindas